Latest news with #TDCowen
Business Insider
an hour ago
- Business
- Business Insider
Analysts Offer Insights on Technology Companies: Sensata (ST) and Develop Global Limited (OtherVTEXF)
There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Sensata (ST – Research Report) and Develop Global Limited (VTEXF – Research Report) with bullish sentiments. Confident Investing Starts Here: Sensata (ST) TD Cowen analyst Joseph C Giordano maintained a Buy rating on Sensata yesterday and set a price target of $45.00. The company's shares closed last Monday at $25.70, close to its 52-week low of $24.42. According to Giordano is a 5-star analyst with an average return of 7.7% and a 60.7% success rate. Giordano covers the Industrial Goods sector, focusing on stocks such as Watts Water Technologies, Veralto Corporation, and Rockwell Automation. Currently, the analyst consensus on Sensata is a Hold with an average price target of $28.30. Develop Global Limited (VTEXF) In a report issued on May 29, Tim McCormack from Canaccord Genuity maintained a Buy rating on Develop Global Limited, with a price target of A$5.05. The company's shares closed last Tuesday at $1.40. According to McCormack is a top 100 analyst with an average return of 22.7% and a 66.5% success rate. McCormack covers the Basic Materials sector, focusing on stocks such as Northern Star Resources Ltd, Ramelius Resources Limited, and Gascoyne Resources Limited. Currently, the analyst consensus on Develop Global Limited is a Moderate Buy with an average price target of $2.92.
Business Insider
2 hours ago
- Business
- Business Insider
TD Cowen Keeps Their Buy Rating on Braze (BRZE)
In a report released yesterday, Derrick Wood from TD Cowen maintained a Buy rating on Braze (BRZE – Research Report), with a price target of $47.00. Confident Investing Starts Here: According to TipRanks, Wood is a 5-star analyst with an average return of 15.0% and a 62.40% success rate. Wood covers the Technology sector, focusing on stocks such as Oracle, ServiceNow, and Domo. In a report released on May 30, Stifel Nicolaus also maintained a Buy rating on the stock with a $45.00 price target. BRZE market cap is currently $3.97B and has a P/E ratio of -36.06. Based on the recent corporate insider activity of 106 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BRZE in relation to earlier this year. Last month, Jonathan Hyman, the CTO of BRZE sold 9,197.00 shares for a total of $329,988.36.
Business Insider
2 hours ago
- Business
- Business Insider
New Buy Rating for Samsara (IOT), the Technology Giant
TD Cowen analyst Derrick Wood maintained a Buy rating on Samsara (IOT – Research Report) yesterday and set a price target of $51.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Wood is a 5-star analyst with an average return of 15.0% and a 62.40% success rate. Wood covers the Technology sector, focusing on stocks such as Oracle, ServiceNow, and Domo. In addition to TD Cowen, Samsara also received a Buy from BMO Capital's Daniel Jester in a report issued yesterday. However, on the same day, Craig-Hallum assigned a Hold rating to Samsara (NYSE: IOT). The company has a one-year high of $61.90 and a one-year low of $27.14. Currently, Samsara has an average volume of 4.43M. Based on the recent corporate insider activity of 243 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of IOT in relation to earlier this year. Most recently, in March 2025, Dominic Phillips, the EVP, CFO of IOT sold 54,134.00 shares for a total of $2,089,223.66.
Yahoo
2 hours ago
- Business
- Yahoo
Why Tempus AI, Inc. (TEM) Skyrocketed On Monday
We recently published a list of . In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other top-performing stocks on Monday. Tempus AI extended its winning streak to a third consecutive day on Monday, jumping 15.02 percent to close at $63.47 apiece as investors snapped up shares after earning a 'buy' recommendation despite being hit by a negative short-seller report. On Monday, TD Cowen maintained its 'buy' recommendation on Tempus AI, Inc.'s (NASDAQ:TEM), pricing it at $62, albeit lower than its latest closing price. The recommendation followed Spruce Point Capital's report on the company, saying it sees a '50 to 60 percent potential long-term downside and market underperformance risk.' Photo by CDC on Unsplash 'We believe the Tempus equity growth story is built on hype and appeal to retail investors that it is an exciting and disruptive technology play with AI appeal, which could have the next Tesla or Nvidia-type inflection,' Spruce Point was quoted as saying. For its part, Tempus AI, Inc. (NASDAQ:TEM) said that it would not respond to a report 'riddled with hypotheticals and inaccuracies.' 'We remain focused on delivering shareholder value, taking advantage of the enormous opportunity of bringing AI to healthcare, and helping patients live longer and healthier lives,' it said. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
5 hours ago
- Business
- Yahoo
Why Tempus AI, Inc. (TEM) Skyrocketed On Monday
We recently published a list of . In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against other top-performing stocks on Monday. Tempus AI extended its winning streak to a third consecutive day on Monday, jumping 15.02 percent to close at $63.47 apiece as investors snapped up shares after earning a 'buy' recommendation despite being hit by a negative short-seller report. On Monday, TD Cowen maintained its 'buy' recommendation on Tempus AI, Inc.'s (NASDAQ:TEM), pricing it at $62, albeit lower than its latest closing price. The recommendation followed Spruce Point Capital's report on the company, saying it sees a '50 to 60 percent potential long-term downside and market underperformance risk.' Photo by CDC on Unsplash 'We believe the Tempus equity growth story is built on hype and appeal to retail investors that it is an exciting and disruptive technology play with AI appeal, which could have the next Tesla or Nvidia-type inflection,' Spruce Point was quoted as saying. For its part, Tempus AI, Inc. (NASDAQ:TEM) said that it would not respond to a report 'riddled with hypotheticals and inaccuracies.' 'We remain focused on delivering shareholder value, taking advantage of the enormous opportunity of bringing AI to healthcare, and helping patients live longer and healthier lives,' it said. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
